Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 05, 2005. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial performance data.
Material Changes
The filing details two specific transactions involving the GlaxoSmithKline Employee Trust ("GSK Trust") and the SmithKline Beecham Employee Share Option Plan 1991:
- May 3, 2005: The GSK Trust transferred 30,104 Ordinary Shares to plan participants.
- May 4, 2005: The GSK Trust transferred 40,373 Ordinary Shares to plan participants.
Three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) hold interests in the shares held by the GSK Trust in the same capacity as other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Points
- Verify the total number of shares transferred to the Employee Share Option Plan (70,477 shares across two days).
- Confirm the continued status of the GSK Trust as a discretionary trust for current and former employees.
- Note that this filing does not contain operational or financial results for the period.